AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

CeMines receives multiple USPTO patent-Issue Notifications, two of which protect its discovery of a significant new class of oncology targets for diagnostic and therapeutic applications.

Chemical Business Newsbase

| November 30, 2005 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Press Release)

CeMines Inc has received multiple Issue Notifications from the US Patent & Trademark Office (USPTO). On 8 Nov 2005, the company received an Issue Notification for US Patent No 6,962,985 and its claims directed to Mammalian Neuralized Family Transcriptional Regulators. Additionally, CeMines announced that it also received a term adjustment of 462 days related to this important patent. The Neuralized patent protects discovery of polynucleotides that encode novel transcriptional suppressors characterized by the presence of a neutralised homology repeat domain and a C3HC4 RING-zinc finger …

Related articles from newspapers, magazines, journals, and more
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily